Literature DB >> 19955345

Neurooncology of familial cancer syndromes.

Andreas F Hottinger1, Yasmin Khakoo.   

Abstract

The majority of tumors of the nervous system are sporadic. However, a subset of patients with tumors and their families are predisposed to developing cancers of the central nervous system and other organs because of a germline mutation. In the last decade, many of the genes responsible for these typically autosomal dominant familial tumor syndromes have been identified. Additionally, our understanding of the mechanisms of carcinogenesis in these syndromes has increased, allowing for more targeted therapies for these patients as well as those with sporadic cancers. Because these patients present a unique set of issues regarding diagnosis and neurooncological management, the most common familial cancer syndromes involving the nervous system are reviewed: neurofibromatosis type 1 and 2; tuberous sclerosis complex; von Hippel Lindau, Li-Fraumeni, Gorlin, and Turcot syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19955345     DOI: 10.1177/0883073809337539

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  Cranial Ewing's sarcoma in children.

Authors:  Maria Moschovi; George A Alexiou; Natalia Tourkantoni; Mirsini-Ersi Balafouta; Christos Antypas; Maria Tsiotra; George Sfakianos; Neofytos Prodromou
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

Review 2.  Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.

Authors:  Soumen Khatua; Jason Wang; Veena Rajaram
Journal:  Childs Nerv Syst       Date:  2015-02-27       Impact factor: 1.475

3.  Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.

Authors:  Anita Villani; David Malkin; Uri Tabori
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 4.  The molecular classification of medulloblastoma: driving the next generation clinical trials.

Authors:  Sarah E S Leary; James M Olson
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

5.  Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013.

Authors:  Diana R Withrow; Amy Berrington de Gonzalez; Clara J K Lam; Katherine E Warren; Meredith S Shiels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-21       Impact factor: 4.254

6.  Simultaneous colonic adenocarcinoma and medulloblastoma in a 12-year-old with biallelic deletions in PMS2.

Authors:  Holly Lindsay; Rima F Jubran; Larry Wang; Benjamin R Kipp; William A May
Journal:  J Pediatr       Date:  2013-04-10       Impact factor: 4.406

Review 7.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

Review 8.  The molecular landscape of pediatric brain tumors in the next-generation sequencing era.

Authors:  Marlo R Firme; Marco A Marra
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

Review 9.  Meningioma.

Authors:  Ali-Reza Fathi; Ulrich Roelcke
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 10.  Case-based review: pediatric medulloblastoma.

Authors:  Cassie N Kline; Roger J Packer; Eugene I Hwang; David R Raleigh; Steve Braunstein; Corey Raffel; Pratiti Bandopadhayay; David A Solomon; Mariam Aboian; Soonmee Cha; Sabine Mueller
Journal:  Neurooncol Pract       Date:  2017-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.